Infective Endocarditis and Antimicrobial Timing: A Case for Delay?
Open Access
- 29 September 2025
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (10) , ofaf628
Abstract
Background: In patients with suspected infective endocarditis (IE), current guidelines recommend prompt initiation of empiric antimicrobial treatment after obtaining blood cultures. However, the clinical benefit of immediate treatment in hemodynamically stable patients remains uncertain. This study assessed the impact of deferring antimicrobial treatment in patients with suspected IE. Methods: We conducted a multicenter cohort study of adult patients with bacteremia and clinical suspicion of IE from 2 university hospitals (2015–24). Patients presenting with sepsis, intensive care unit admission, neutropenia, or a clearly identifiably focus other than IE were excluded. All cases were adjudicated by a dedicated Endocarditis Team as either IE or not IE. The primary outcome for all episodes was 30-day mortality; for confirmed IE cases, the composite outcome included 30-day mortality, new embolic events, or new bone and joint infection. Results: Among 1230 episodes, empirical antimicrobial treatment was initiated immediately (Group I) after blood culture collection in 675 episodes (55%) and deferred until preliminary blood culture results (Group D) in 555 episodes (45%). Thirty-day mortality was 5% (59 episodes), with no difference between Groups I and D (5% vs 5%; P = .894). Of 597 confirmed IE episodes (49%) IE, 327 (55%) were in Group I and 270 (45%) in Group D. The composite primary endpoint occurred in 157 episodes (26%), with no difference between groups (28% vs 24%; P = .304). Conclusions: In clinically stable patients with suspected IE, deferring antimicrobial treatment until available blood culture results was not associated with worse clinical outcomes.Keywords
Funding Information
- Swiss National Science Foundation (#32003B_219351/1)
- Swiss Heart Foundation (#FF24013)
- Vaudois Foundation for Interventional Cardiology
This publication has 30 references indexed in Scilit:
- Factors associated with persistent bacteraemia among patients with suspected infective endocarditisInfection, 2025
- Impact of rapid identification by MALDI-TOF MS from positive blood cultures in Enterococcus spp. bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2025
- Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM): a systematic review and Delphi surveyClinical Microbiology and Infection, 2024
- Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditisInfection, 2023
- Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardshipClinical Microbiology and Infection, 2021
- Clinical and echocardiographic predictors of embolism in infective endocarditis: systematic review and meta-analysisClinical Microbiology and Infection, 2019
- Blood culture-based diagnosis of bacteraemia: state of the artClinical Microbiology and Infection, 2015
- Global and Regional Burden of Infective Endocarditis, 1990–2010: A Systematic Review of the LiteratureGlobal Heart, 2014
- The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS)American Heart Journal, 2007